The participants’ risk status for cognitive decline associated with Alzheimer’s disease had been previously determined for a longitudinal study and defined as cognitively healthy with normal Aβ42/total tau protein ratio (CH-NATs, low-risk) or pathological ratio (CH-PATs, high-risk). Here, MAPT is linked to Mental deterioration.